Traynor Capital Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8K | Sell |
18,610
-13,490
| -42% | -$34.7K | ﹤0.01% | 249 |
|
|
2025
Q1 | $96.6K | Buy |
32,100
+500
| +2% | +$1.51K | 0.01% | 215 |
|
|
2024
Q4 | $80.9K | Buy |
31,600
+1,110
| +4% | +$2.84K | 0.01% | 230 |
|
|
2024
Q3 | $113K | Sell |
30,490
-210
| -0.7% | -$781 | 0.01% | 223 |
|
|
2024
Q2 | $194K | Buy |
30,700
+8,200
| +36% | +$51.8K | 0.01% | 204 |
|
|
2024
Q1 | $121K | Buy |
22,500
+5,450
| +32% | +$29.3K | 0.01% | 216 |
|
|
2023
Q4 | $85.6K | Buy |
17,050
+2,100
| +14% | +$10.5K | 0.01% | 200 |
|
|
2023
Q3 | $25.3K | Buy |
+14,950
| New | +$25.3K | ﹤0.01% | 192 |
|